Can the personalized medicine approach contribute in controlling tuberculosis in general and India in particular?
| Autor: | Aparup Das, Nikhat Khan |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Tuberculosis business.industry Isoniazid General Medicine medicine.disease 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Nat2 gene Medicine 030212 general & internal medicine Personalized medicine business Intensive care medicine medicine.drug |
| Zdroj: | Precision Clinical Medicine. 3:240-243 |
| ISSN: | 2516-1571 2096-5303 |
| Popis: | Poor drug compliance and drug-resistant Mycobacterium tuberculosis are the two principal obstacles in controlling tuberculosis (TB) in endemic regions including India, which has contributed the most to global TB burden. We argue here that a personalized medicine approach, to start with the N-acetyl transferase-2–isoniazid (NAT2–INH) model, could be a step forward in dealing with both these limitations in controlling TB in India. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|